INSIGHTS ON DRUG DEVELOPMENT

• Facilitate Handling Of Bulk Powders With Dry Granulation

  Handling bulk powders in manufacturing presents serious challenges—from unpredictable caking to safety risks—that can disrupt workflows. Discover solutions to streamline operations and protect your team.

• Cell Culture Automation Of The 3D Cancer Spheroid Assay

  Discover how automated 3D cell culture methods enhance efficiency and consistency in high-throughput drug screening to accelerate the discovery of new anti-cancer therapies.

• Solving The Inhalation Puzzle: A CDMO's Guide To Dry Powder Development

  Gain guidance on the choice of formulation, excipients, and the micronization technologies offered by CDMOs, and learn about current encapsulation technologies for inhaled products.

• Accelerate Your pDNA And mRNA Process Development

  Explore a structured approach to optimizing and scaling plasmid DNA production using E. coli, with insights into key growth parameters, benchtop feasibility, and pilot-scale performance.

• Navigating Challenges During Formulation Development

  9/11/2024

  Gain valuable knowledge on addressing formulation stability, improving product shelf life, and enhancing overall product performance in biopharmaceutical studies.

• Reduce Costly Scale-Up Problems

  4/11/2024

  Scaling a new drug formulation from development to manufacturing often presents challenges, but there are ways to minimize deviations and streamline your transition.

• Engineering The Future Of Lipsomal Drug Delivery

  5/14/2025

  Explore our full collection of case studies to discover how liposome technology is transforming drug delivery across a wide range of therapies.

• Take The Wheel And Drive Your Oligo Synthesis Where You Want

  2/9/2026

  Explore the evolving oligo therapeutic landscape while identifying common challenges of bringing production in‑house and the key factors that shape long‑term success for smoother scale‑up.

• A Human-Relevant Model Of The Liver Sinusoid

  11/7/2024

  This organ-on-a-chip model minimizes drug absorption while maintaining the essential architecture. Explore the specifications of this product engineered to model the human liver.